Global High Content Screening Market is anticipated to expand at a 5.8% CAGR, reaching US$ 3 Billion by 2033 | Future Market Insights, Inc.

The pharmaceutical and healthcare industries are the primary drivers of the high demand for High Content Screenings. Germany, accounting for over 7.3% of total demand in Europe in 2022, has emerged as a significant market. Furthermore, China is expected to experience a robust growth rate with a CAGR of 7.8% over the next decade


NEWARK, Del, May 24, 2023 (GLOBE NEWSWIRE) -- The global high-content screening market is predicted to reach US$ 3 Billion by 2033. The market for high-content screening will expand favorably, and in 2022, its total estimated value is expected to exceed US$ 1.6 Billion. A projected CAGR of 5.8% in terms of sales volume (units) indicates that there will be a sharp increase in demand for high-content screenings.

Cellomics and high content screening (HCS) are related terms. It is a technique used in biological research and drug discovery to find new drug candidates. Digital microscopy and flow cytometry are the main foundations of high-content screening systems, along with a combination of IT systems for the storage and analysis of biological data.

The pharmaceutical industry has found that high content screening techniques are very effective for characterizing preclinical drugs. This technology frequently coexists with a variety of other uses, like drug development. The use of HCS in conjunction with chemical genetics to study biological systems is expected to grow over the next few years.

Drivers and Challenges have an Impact on Market Dynamics, which can Impact Businesses. Find more details in our Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-426

Key Takeaways

  • The CAGR for the global market over the preceding period was 5.1%.
  • Over the coming decades, the market in India is anticipated to grow at a CAGR of 6.6%.
  • With more than 7.3% of all demand recorded in Europe in 2022, Germany has emerged as a major market.
  • Over the coming decade, the market in China is anticipated to grow at a CAGR of 7.8%.
  • The highest demand for High Content Screenings came from the pharmaceutical and healthcare industries.

The rising prevalence of multiple infectious diseases with a variety of symptoms raises the demand for innovative treatments. As a result, there will be an increase in biotechnology and pharmaceutical study and development efforts to identify new drug candidates. Imaging technologies are becoming increasingly important in drug discovery and analysis.” says an FMI analyst.

Competitive Landscape

Key players in the HCS market employ strategies such as mergers and acquisitions, product launches, collaborations, and alliances to expand their businesses.

  • Particle Works, a progressive company that creates and markets cutting-edge particle engineering platforms, declared the release of the Automated Library Synthesis (ALiS) System, a new ground-breaking platform, in November 2022. This innovative platform favors automation in the early stages of the creation of drugs as well as high-throughput evaluation of lipid nanoparticle (LNP) formulations and mRNA candidates.
  • The Twist High Throughput Antibody Production platform, developed by California-based Twist Bioscience Corporation, was made public in April 2022. It allows customers to convert candidate genetic sequences into cleansed antibodies for use in a variety of applications related to screening and therapeutic discovery projects.

Are you looking for more details about the latest trends, drivers, and challenges? Speak to Our Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-426

Key Companies Profiled

  • Thermo Fisher Scientific Inc.
  • Becton Dickinson, and Company
  • GE Healthcare
  • Olympus Corporation
  • PerkinElmer Inc.
  • Sysmex Corporation
  • Merck KGaA
  • Danaher Corporation
  • Yokogawa Electric Corporation
  • BioTek Instruments Inc.

More Valuable Insights

Future Market Insights, in its new offering, presents an unbiased analysis of the global high-content screening market presenting a historical analysis from 2018 to 2022 and forecast statistics for the period of 2023 to 2033.

The study reveals essential insights by product type (cell imaging & analysis, consumables, software, services), industry (pharmaceutical & healthcare, biotechnology, educational institutions, independent CROs, government organizations), application & region.

Buy Now and Gain Access to Identify Key Trends, Drivers, and Challenges in the Market @ https://www.futuremarketinsights.com/checkout/426

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand-side Trends

1.3. Supply-side Trends

1.4. Technology Roadmap Analysis

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Market Dynamics

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity

3.1.4. Trends

3.2. Scenario Forecast

3.2.1. Demand in Optimistic Scenario

3.2.2. Demand in Likely Scenario

3.2.3. Demand in Conservative Scenario

3.3. Opportunity Map Analysis

3.4. Product Life Cycle Analysis

3.5. Supply Chain Analysis

3.5.1. Supply Side Participants and their Roles

3.5.1.1. Producers

3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

3.5.1.3. Wholesalers and Distributors

3.5.2. Value Added and Value Created at Node in the Supply Chain

3.5.3. List of Raw Material Suppliers

3.5.4. List of Existing and Potential Buyer’s

3.6. Investment Feasibility Matrix

3.7. Value Chain Analysis

3.7.1. Profit Margin Analysis

3.7.2. Wholesalers and Distributors

3.7.3. Retailers

3.8. PESTLE and Porter’s Analysis

3.9. Regulatory Landscape

3.9.1. By Key Regions

3.9.2. By Key Countries

3.10. Regional Parent Market Outlook

3.11. Production and Consumption Statistics

3.12. Import and Export Statistics

Complete TOC: https://www.futuremarketinsights.com/toc/rep-gb-426

Have a Look at Related Research Reports in the Healthcare Domain:

Neonatal Thermoregulation Market Size: The global neonatal thermoregulation market is estimated at US$ 661.8 million in 2023. The market is projected to reach US$ 1,151.6 million by 2033, exhibiting a CAGR of 5.7% from 2023 to 2033.

Gene Prediction Tools Market Share: The global gene prediction tools market size is projected to be worth US$ 127.3 million in 2023. The market is likely to surpass US$ 680.9 million by 2033. It is set to expand at a CAGR of 18.3% during the forecast period.

Veterinary Sutures Market Growth: According to Future Market Insights research, during the projected period, the global veterinary sutures market is expected to grow at a CAGR of 3.8%. The market value is projected to increase from US$ 333.38 Million in 2023 to US$ 482.1 Million by 2033.

Refurbished Dental Equipment Market Trend: According to Future Market Insights Research, during the projected period, the global refurbished dental equipment market is expected to grow at a CAGR of 8.7%. The market value is projected to increase from US$ 797.3 Million in 2023 to US$ 1.8 Billion by 2033.

IV Disposables Market Forecast: According to Future Market Insights research, during the projected period, the global IV disposables market is expected to grow at a CAGR of 11.8%. The market value is projected to increase from US$ 17.0 Billion in 2023 to US$ 51.6 Billion by 2033.

Digital Psychotherapeutics Market Sales: The global digital psychotherapeutics market size is projected to be worth US$ 1.06 billion in 2023. Over the next ten years, global digital psychotherapeutics demand is likely to accelerate at 27.6% CAGR. By 2033, the total market value is expected to surpass US$ 12.2 billion.

Clinical Research Organization Market Analysis: According to Future Market Insights (FMI) analysis in a recent market survey, the global clinical research organization market was valued at US$ 58.0 Billion in 2022 and is expected to reach US$ 139.6 Billion by 2033.

Mastectomy Reconstruction Implants Market Outlook: According to Future Market Insights (FMI) analysis in a recent market survey, the global mastectomy reconstruction implants market was valued at US$ 1.95 Billion in 2022 and is set to reach US$ 4.69 Billion by 2033.

Pulmonology Devices Market Volume: The global pulmonology devices market is estimated at US$ 1.4 billion in 2023. The market is projected to reach US$ 3.8 billion by 2033, exhibiting a CAGR of 10.3% from 2023 to 2033.

Esophageal Implant Market Application: The global esophageal implant market size is estimated to reach US$ 147.0 million in 2023. From 2023 to 2033, global esophageal implant sales are projected to soar at 6.7% CAGR. By the end of 2033, the total market value is likely to exceed US$ 280.2 million.

About Future Market Insights (FMI):

Future Market Insights, Inc. (ESOMAR certified, Stevie Award - recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10 years.

Contact Us:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
LinkedInTwitterBlogs | YouTube
For Sales Enquiries: sales@futuremarketinsights.com